Blood pressure medicine recalled over potentially 'life-threatening' mix-up

Henrietta Brewer
August 31, 2018

According to the FDA, Accord Healthcare is voluntarily recalling certain bottles of 12.5 mg hydrochlorothiazide tablets after a 100-count bottle of the drug was found to contain a different medicine.

Those who are prescribed to take Accord's Hydrochlorothiazide Tablets USP 12.5 should make sure the pills are light orange to peach colored, round, and biconvex in shape.

A pair of nationwide recalls, including tablets from different brand names and manufacturers, say that patients could face risky reactions or increase their cancer risk by taking unsafe or incorrect medication.


Spironolactone is used to treat a variety of conditions including high blood pressure, congestive heart failure and conditions where there are low levels of potassium in the blood, among other things. Spironolactone can also be used to treat high blood pressure, but the FDA warns that use of spironolactone tablets instead of hydrochlorothiazide tablets poses the risk of contracting hyperkalemia, an increase in potassium levels that be life-threatening to certain individuals.

Accord believes the medication was only switched in lot PW05264.

According to a report from USA Today, the Food and Drug Administration issued the recall due to mislabeled bottles of Hydrochlorothiazide.


The FDA says if you happen to will beget a hydrochlorothiazide prescription and the capsules in your bottle attain no longer match that description, or if you happen to are undecided, return them to your pharmacy or physician.

Not all drugs containing valsartan are being recalled, but this week the FDA expanded the list of drugs being recalled.

If you experience a reaction from your medication, you can report it using the FDA's Medwatch form.


Other reports by iNewsToday

FOLLOW OUR NEWSPAPER